19 – 23 October 2026 | Gold Coast
Follow the capital across Australia’s Biggest Week in Biotech. From emerging innovation and private-company opportunities to public markets, commercialisation and global growth, investors can discover the companies, technologies and capital pathways shaping Australian life sciences.
Welcome to a dedicated place to work between sessions and meetings during the AusBiotech International Conference and AusMedtech Conference, from October 21 to 23.
Located within the Gold Coast Convention and Exhibition Centre, the Investor Workspace provides approved investor delegates with a quiet, comfortable space to catch up on work without leaving the conference. With tables, cafe-style seating and access to venue Wi-Fi, it’s an ideal place to set up between sessions and meetings. The space is designed for focused individual work; networking or company meetings are to be held elsewhere.
Looking for somewhere to hold a meeting or network? Use AusPartnering for scheduled one-to-one meetings in dedicated meeting rooms.
AusPartnering is AusBiotech’s dedicated business matching platform,for one-to-one meetings between delegates, from October 21 to 23. Use it to identify companies and delegates relevant to your investment interests, request one-to-one meetings and build your meeting schedule before you arrive. Move between scheduled meetings, conference sessions and investor-relevant content across the week.
Discover new opportunities across company stages and capital pathways
Wednesday 21 October, 2:15pm
See what the sector is building next. Get an early view of selected Australian life sciences research, technologies and emerging companies moving towards translation, company formation and commercialisation. Meet emerging researchers and founders, hear constructive feedback from an experienced judging panel and discover what is entering the commercialisation pipeline.
Thursday 22 October, 3:50 pm
See what capital could unlock. A fast–paced view of selected private life sciences companies with substantive evidence or external validation, a defined next value–creation milestone and clear capital requirements. Three minutes. No slides. Just the company, the opportunity, the next milestone and how achieving it creates value. Capital Sprint sponsored by Google Cloud.
Wednesday 21 October, 4:30 pm
See what matters now, and what comes next. A rapid view of selected listed life sciences companies, their substantive recent progress and significant clinical, regulatory, commercial or strategic milestones ahead. Three minutes. No slides. Investors hear what matters now: current position, recent progress, what comes next and the pathway to shareholder value creation.
Follow the pathways to global growth across the whole conference, from October 21 to 23. Explore dedicated conference content on how Australian life science companies are financing, commercialising, partnering and scaling internationally and what those pathways mean for investors.
Located in the heart of the exhibition hall, BioInnovation Spotlight presentations give investors another way to discover technologies, companies, products and innovative solutions from across the life sciences ecosystem through focused ten-minute presentations.
Taking place during Australia’s Biggest Week in Biotech, AusBiotech Invest is a dedicated and highly curated life sciences investment forum bringing together active investors around a small number of significant financing situations for substantive capital discussion and engagement. Investor attendance is by Expression of Interest and subject to eligibility criteria. Registration for the AusBiotech International Conference and AusMedtech Conference does not provide access to AusBiotech Invest. Confirmed attendees of AusBiotech Invest can add on registration for the AusBiotech International Conference and AusMedtech Conference program. For more information please contact invest@ausbiotech.org or apply to attend below.
From emerging innovation and venture opportunities to public markets and global growth, Australia’s Biggest Week in Biotech puts investors closer to the opportunities shaping Australian life sciences
